Prevalence of Mental Health Issues in Endurance Athletes.

November 30, 2023 updated by: Volker Scheer, Ultra Sports Science Foundation
Participation in endurance sports has been increasing over the last few decades and our aim of our exploratory descriptive survey study is therefore to examine mental health issues in endurance athletes (marathon runners, ultra endurance runners, triathletes), employing the IOC assessment tool, to provide information on mental health issues in this population. Secondary objects are to evaluate risk factors for mental health issues in endurance athletes (like exercise behaviour, competition behaviour, age, gender, medical issues)

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This study is an exploratory descriptive survey study.

The study protocol will be largely replicated from the IOC consensus paper and the questionnaires based according to SMHAT 1 with an athlete-specific screening tool (APSQ) and further eleven subsequent disorder-specific screening tools:

Eleven disorder specific screening tools:

  1. General Anxiety Disorder-7 (GAD-7): assesses the presence of symptoms of anxiety.
  2. Patient Health Questionnaire-9 (PHQ-9): assesses the presence of symptoms of depression.
  3. Athlete Sleep Screening Questionnaire (ASSQ): assesses the presence of sleep disturbance.
  4. Alcohol Use Disorders Identification Test Consumption (AUDIT-C): assesses the presence of alcohol misuse.
  5. Cutting Down, Annoyance by Criticism, Guilty Feeling, and Eye-openers Adapted to Include Drugs (CAGE-AID): assesses the presence of substance misuse, being slightly adapted for the SMHAT (no focus on alcohol use as already explored with the AUDIT-C; additional question to explore which substance was used).
  6. Brief Eating Disorder in Athletes Questionnaire (BEDA-Q): assesses the presence of disordered eating.
  7. ADHD
  8. Bipolar disorder
  9. PTSD
  10. Gambling
  11. Psychosis

Additionally questions to assess exercise addiction will be used as it has been shown that exercise addiction may be particularly prevalent in endurance athletes.

Further questions about age, gender, country of origin, training data, past medical history and medication will be asked as well as a few specific questions about there thoughts on mental health issues as per IOC consensus paper

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Pierre-Bénite, France, 69310

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Particpants that have or are participating in endurance sports

Description

Inclusion Criteria:

  • endurance athletes (marathon runners, ultramarathon runners and triathletes)
  • over the age of 16
  • all genders
  • recreational athletes (non- elite)
  • elite athletes (professional, international, college level)

Exclusion Criteria:

  • athletes that that are not competing or have not competed in an official endurance race
  • athletes that are younger than 16 years of age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
endurance athletes
participants that have or are participating in endurance sports
survey on mental health issues in endurance athletes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with mental health issues
Time Frame: March-September 2023
Number of participants with mental health issues
March-September 2023

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with risk factors associated with mental health issues
Time Frame: March-September 2023
Number of participants with risk factors associated with mental health issues
March-September 2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Volker Scheer, Prof, Ultra Sports Science Foundation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2023

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

September 30, 2024

Study Registration Dates

First Submitted

March 3, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 14, 2023

Study Record Updates

Last Update Posted (Actual)

December 1, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VS1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

anonymous

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression, Anxiety

Clinical Trials on mental health issues

3
Subscribe